Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL1RL1 antibody

The Rabbit Polyclonal anti-IL1RL1 antibody (ABIN1169349) specifically detects IL1RL1 in WB, ELISA and FACS. The antibody is reactive with Human samples.
Catalog No. ABIN1169349
$438.44
Plus shipping costs $50.00
Shipping to: United States
Delivery in 5 to 10 Business Days

Quick Overview for IL1RL1 antibody (ABIN1169349)

Target

See all IL1RL1 Antibodies
IL1RL1 (Interleukin 1 Receptor-Like 1 (IL1RL1))

Reactivity

  • 91
  • 13
  • 4
  • 2
  • 1
Human

Host

  • 55
  • 25
  • 13
  • 1
  • 1
Rabbit

Clonality

  • 56
  • 39
Polyclonal

Conjugate

  • 55
  • 8
  • 5
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This IL1RL1 antibody is un-conjugated

Application

  • 43
  • 28
  • 22
  • 15
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Flow Cytometry (FACS)
  • Purpose

    anti-ST2 (human), pAb

    Specificity

    Recognizes soluble human ST2. Detects a band of ~50 kDa by Western blot and the endogenous ST2 by Flow Cytometry.

    Characteristics

    Polyclonal Antibody. Recognizes soluble human ST2. Detects a band of ~50 kDa by Western blot and the endogenous ST2 by Flow Cytometry. Source: Rabbit. Applications: ELISA, FACS, WB. Liquid. In PBS containing 0.02 % sodium azide. ST2 is a member of the Toll/IL-1 receptor family. Two forms of the protein exist, a soluble form known as ST2 and a membrane anchored form known as ST2L. The membrane form is expressed by Th2 cells and bone marrow derived mast cells, whereas the soluble form is expressed by serum-stimulated fibroblasts. It binds IL-33 and is structurally similar to IL-1R1. Type 2 innate lymphoid cells (ILC2), originally referred to as natural helper (NH) cells, are a novel target of IL-33. Lung ILC2s participate in the induction of airway inflammation in influenza virus-infected mice and papain-administrated mice. Soluble ST2 plays a role in protecting ILC2 from IL-33 stimulation and thereby maintaining them in a naive state and might be important for the regulation of several disease. Blocking with anti-ST2 antibodies has been shown to alleviate experimental arthritis and airway inflammation. The IL-33-ST2 axis is is involved across a range of diseases including asthma, allergies, obesity and cardiac disease.

    Immunogen

    Recombinant human soluble ST2.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    In PBS containing 0.02 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Storage

    4 °C,-20 °C

    Storage Comment

    +4°C

    -20°C

    Stable for at least 6 months after receipt when stored at -20°C.

    Expiry Date

    6 months
  • Target

    IL1RL1 (Interleukin 1 Receptor-Like 1 (IL1RL1))

    Alternative Name

    ST2

    Background

    Alternate Names/Synonyms: Interleukin-1 Receptor-like 1, IL-1 Receptor-like 1, IL1RL1, Interleukin-33 Receptor, IL-33-Receptor

    Product Description: ST2 is a member of the Toll/IL-1 receptor family. Two forms of the protein exist, a soluble form known as ST2 and a membrane anchored form known as ST2L. The membrane form is expressed by Th2 cells and bone marrow derived mast cells, whereas the soluble form is expressed by serum-stimulated fibroblasts. It binds IL-33 and is structurally similar to IL-1R1. Type 2 innate lymphoid cells (ILC2), originally referred to as natural helper (NH) cells, are a novel target of IL-33. Lung ILC2s participate in the induction of airway inflammation in influenza virus-infected mice and papain-administrated mice. Soluble ST2 plays a role in protecting ILC2 from IL-33 stimulation and thereby maintaining them in a naive state and might be important for the regulation of several disease. Blocking with anti-ST2 antibodies has been shown to alleviate experimental arthritis and airway inflammation. The IL-33-ST2 axis is is involved across a range of diseases including asthma, allergies, obesity and cardiac disease.

    UniProt

    Q01638
You are here:
Chat with us!